Sugentech Inc. Share Price

A253840

KR7253840003

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 30/09/2026			5-day change	1st Jan Change
4,440.00 ^KRW	+1.02%		-1.33%	-27.69%

08-14	Sugentech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Sugentech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.

Employees

144

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
29/09/26	₩4,440.00	+1.02%	87,788
29/09/26	₩4,395.00	-4.35%	121,887
28/09/26	₩4,595.00	+0.66%	96,979
23/09/26	₩4,565.00	+1.44%	134,603
22/09/26	₩4,500.00	0.00%	90,769

End-of-day quote Korea S.E.

More quotes

Market Cap	67.89B 50.12M 44.13M 41.81M 37.75M 71.15M 4.81B 72.07M 500M 193M 2.46B 188M 184M 7.88B	P/E 2024	-5.35x	P/E 2025	-4.03x
Enterprise Value	37.68B 27.82M 24.5M 23.21M 20.95M 39.49M 2.67B 40M 278M 107M 1.36B 104M 102M 4.37B	EV / Sales 2024	3.27x	EV / Sales 2025	6.76x
Free-Float	76.84%	Yield 2024 *	-	Yield 2025	-

08-14	Sugentech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Sugentech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-18	Sugentech Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-14	Sugentech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
29/08/25	Sugentech to divest 12.5 billion won worth of own shares	RE
28/08/25	Sugentech Inc. announced that it expects to receive KRW 12.506195 billion in funding from Synergy IB Investment Co., Ltd., Synergy-Premier Mezzanine Blind No. 1 New Technology Business Investment Fund, IBK Capital Corporation, Korea Investment & Securities Co., Ltd. and other investors	CI
14/08/25	Sugentech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/05/25	Sugentech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
11/03/25	Sugentech Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
10/03/25	Sugentech Inc. Auditor Raises 'Going Concern' Doubt	CI
14/11/24	Sugentech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
22/09/24	Sugentech Inc.(KOSDAQ:A253840) dropped from S&P Global BMI Index	CI
28/12/23	Tranche Update on Sugentech Inc.'s Equity Buyback Plan announced on March 29, 2023.	CI

1 day	+1.02%
1 week	-1.33%
Current month	-0.11%
1 month	-3.06%
3 months	+13.41%
6 months	-6.23%
Current year	-27.69%

1 week	4,350	4,650
1 month	4,205	4,845
Current year	3,530	8,170
1 year	3,530	8,250
3 years	3,530	11,500
5 years	3,530	23,750
10 years	3,530	65,800

Manager	Title	Age	Since
Seong-Bum Yoo CTO	Chief Tech/Sci/R&D Officer	59	25/09/2017
Mi-Jin Sohn CEO	Chief Executive Officer	61	25/09/2017
Hae-Gwon Lee DFI	Director of Finance/CFO	56	30/03/2022

Sugentech Inc. Share Price

Stocks

A253840

KR7253840003

Medical Equipment, Supplies & Distribution

Valuation: Sugentech Inc.

Chart: Sugentech Inc.

Latest news: Sugentech Inc.

Press Releases: Sugentech Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Sugentech Inc.

Latest insider transactions

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

Director	Title	Age	Since
Mi-Jin Sohn BRD	Director/Board Member	61	25/09/2017
Seong-Bum Yoo BRD	Director/Board Member	59	25/09/2017
Jae-Hong Jeon BRD	Director/Board Member	51	30/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUGENTECH INC.	+1.02%	-1.33%	-	-	49.55M
Average	+1.02%
Weighted average by Cap.	+1.02%

	2024	2025
Net sales	10.1B 7.45M 6.56M 6.22M 5.61M 10.58M 715M 10.72M 74.41M 28.63M 365M 27.99M 27.38M 1.17B	9.42B 6.95M 6.12M 5.8M 5.24M 9.87M 667M 10M 69.4M 26.71M 341M 26.1M 25.53M 1.09B
Net income	-15.19B -11.22M -9.88M -9.36M -8.45M -15.92M -1.08B -16.13M -112M -43.09M -550M -42.12M -41.2M -1.76B	-23.31B -17.21M -15.16M -14.36M -12.96M -24.43M -1.65B -24.75M -172M -66.12M -844M -64.63M -63.22M -2.7B
Net Debt	-48.51B -35.81M -31.53M -29.88M -26.97M -50.84M -3.43B -51.49M -357M -138M -1.76B -134M -132M -5.63B	-30.2B -22.3M -19.63M -18.6M -16.79M -31.65M -2.14B -32.06M -223M -85.65M -1.09B -83.72M -81.9M -3.5B